Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Boster

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Archives of Neurology|May 13, 2009
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative studyAaron Boster, Stephanie Hreha, Joseph R Berger, et al.
Scientific Reports|May 16, 2026
The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosisDelphine Van Laethem, Lars Costers, Augusto Miravalle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2021
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing dataAlasdair J Coles, Joanne L Jones, Patrick Vermersch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studiesBart Van Wijmeersch, Barry A Singer, Aaron Boster, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Frontiers in Neurology|April 11, 2019
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical SettingsKrista Barclay, Robert Carruthers, Anthony Traboulsee, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Archives of Neurology|May 13, 2009
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative studyAaron Boster, Stephanie Hreha, Joseph R Berger, et al.
Scientific Reports|May 16, 2026
The relationship between objective and subjective cognitive performance and clinical and MRI disease burden in early multiple sclerosisDelphine Van Laethem, Lars Costers, Augusto Miravalle, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 9, 2021
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing dataAlasdair J Coles, Joanne L Jones, Patrick Vermersch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 2, 2019
Efficacy of alemtuzumab over 6 years in relapsing-remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studiesBart Van Wijmeersch, Barry A Singer, Aaron Boster, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 30, 2022
Toward Precision Phenotyping of Multiple SclerosisDavid Pitt, Chih Hung Lo, Susan A Gauthier, et al.
Frontiers in Neurology|April 11, 2019
Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical SettingsKrista Barclay, Robert Carruthers, Anthony Traboulsee, et al.
Pageof 3